Copyright
©The Author(s) 2023.
World J Transplant. Jun 18, 2023; 13(4): 138-146
Published online Jun 18, 2023. doi: 10.5500/wjt.v13.i4.138
Published online Jun 18, 2023. doi: 10.5500/wjt.v13.i4.138
Table 2 Cox multivariate time-to-event analysis demonstrating the association between pre-transplant reflux testing and reduction in chronic rejection (chronic lung allograft dysfunction) in cystic fibrosis patients, after controlling for confounders, suggesting that reflux testing and timely treatment may reduce rejection in this patient cohort
Covariate | Cox multivariate analysis hazard ratios for chronic lung allograft dysfunction | P |
Pre-transplant reflux testing | 0.26 (0.08-0.92) | 0.03 |
Gastroesophageal reflux symptoms before transplant | 3.13 (1.03-9.54) | 0.04 |
Forced expiratory volume in 1 second before transplant | 3.17 (0.61-16.4) | 0.17 |
Body mass index | 0.98 (0.75-1.28) | 0.88 |
Age at transplant | 0.98 (0.90-1.05) | 0.54 |
- Citation: Lo WK, Flanagan R, Sharma N, Goldberg HJ, Chan WW. Pre-Lung transplant reflux testing demonstrates high prevalence of gastroesophageal reflux in cystic fibrosis and reduces chronic rejection risk. World J Transplant 2023; 13(4): 138-146
- URL: https://www.wjgnet.com/2220-3230/full/v13/i4/138.htm
- DOI: https://dx.doi.org/10.5500/wjt.v13.i4.138